Unilabs York Bioanalytical Solutions (YBS) has a history of employing cutting edge technology to maintain its place as Europe’s premier, independent bioanalytical facility. As part of this commitment to providing the latest technology to its clients, YBS is pleased to announce the acquisition of new systems that will help the company énhance its ability to provide high quality bioanalytical data to its clients with increased efficiency.
Two new Waters Xevo TQ-S LC-MS/MS systems will enable the detection and quantification of lower levels of conventional small molecule therapeutics, peptides and oligonucleotides. Linked to Waters Acquity UPLC systems or Spark Holland’s Symbiosis Pharma online, automated online solid phase extraction technology, these systems have proved invaluable in achieving ground breaking levels of sensitivity, selectivity and robustness.
Due to the high demand for sensitive peptide assays YBS has added an additional Spark Holland Symbiosis Pharma online,...